Clinical trial

Hybrid Ablation of Atrial Fibrillation in Heart Failure

NCT05411614

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DEVICE · Unmapped registry intervention AtriCure EPi-Sense-AF Guided Coagulation System +/- Atriclip Find medicine records · Find other trials using this name

DEVICE · Unmapped registry intervention Endocardial Catheter Ablation Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Hybrid Ablation of Atrial Fibrillation in Heart Failure

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2022-06-25

PhaseNA

Conditions

Persistent Atrial Fibrillationverified · MONDO: persistent atrial fibrillation

Atrial Fibrillation, Persistentcandidate · MONDO: persistent atrial fibrillation

Atrial Arrhythmiaunresolved

Atrial Fibrillationverified · MONDO: atrial fibrillation

Heart Failureverified · MONDO: heart failure

Left Ventricular (LV) Systolic Dysfunctionunresolved

Interventions

AtriCure EPi-Sense-AF Guided Coagulation System +/- AtriclipDEVICE

Endocardial Catheter AblationDEVICE

Sponsors & collaborators

St. George's Hospital, Londonlead sponsor

Mapped research locations

LondonUnited Kingdom5

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05411614 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.